St. Louis startups secure millions in latest bioscience funding rounds
Matt Miller/WashU MedicineAn earbud-like device developed by Aurenar, a WashU startup company, has received FDA Breakthrough Device Designation for preventing a dangerous complication of brain bleeding in intensive care patients. The technology is based on clinical trials led by WashU Medicine physician-scientists including Eric Leuthardt, MD.
Source: St. Louis Magazine